Acro Biomedical (ACBM) Common Equity (2015 - 2026)
Acro Biomedical (ACBM) posted Common Equity of -$444789.0 for Q2 2026, down 14.94% on a QoQ basis from -$386964.0 in Q4 2025, and down 40.08% year-over-year from -$742332.0 in Q2 2025.
Powered by 
Analysis
Acro Biomedical (ACBM) Common Equity (2015 - 2026) Analysis & Trends
Acro Biomedical has reported Common Equity for 12 years, with the latest figure at -$444789.0 in Q2 2026.
- On a quarterly basis, Common Equity fell 40.08% year-over-year to -$444789.0 in Q2 2026; TTM through Jun 2026 was -$444789.0, a 40.08% decrease from a year earlier, with the FY2025 full-year figure at $100.0 million, up 34001.52% from the prior year.
- Common Equity was -$444789.0 for Q2 2026 at Acro Biomedical, down from -$386964.0 in the prior quarter.
- The five-year high for Common Equity was $643219.0 in Q1 2022, with the low at -$444789.0 in Q2 2026.
- Average Common Equity over 5 years is -$32906.6, with a median of -$267312.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Common Equity climbed 2.28% in 2022, then plunged 181.38% in 2024.
- Over 5 years, Common Equity stood at $486370.0 in 2022, then slumped by 152.84% to -$257014.0 in 2023, then decreased by 14.77% to -$294972.0 in 2024, then sank by 31.19% to -$386964.0 in 2025, then declined by 14.94% to -$444789.0 in 2026.
- The last three Common Equity figures came in at -$444789.0 (Q2 2026), -$386964.0 (Q4 2025), and -$432619.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 566.00 Mn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 10.55 Bn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 1.87 Bn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | -1.06 Bn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | 1.89 Bn |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 2.52 Bn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -474.50 Mn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 1.46 Bn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | -534,551.00 |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | -444,789.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -444,789.00 |
| Dec 31, 2025 | -386,964.00 |
| Sep 30, 2025 | -432,619.00 |
| Jun 30, 2025 | -317,520.00 |
| Mar 31, 2025 | -303,906.00 |
| Dec 31, 2024 | -294,972.00 |
| Sep 30, 2024 | -285,504.00 |
| Jun 30, 2024 | -276,398.00 |
| Mar 31, 2024 | -267,312.00 |
| Dec 31, 2023 | -257,014.00 |
| Sep 30, 2023 | -239,613.00 |
| Jun 30, 2023 | 339,654.00 |
| Mar 31, 2023 | 410,904.00 |
| Dec 31, 2022 | 486,370.00 |
| Sep 30, 2022 | 492,164.00 |
| Jun 30, 2022 | 574,887.00 |
| Mar 31, 2022 | 643,219.00 |
| Dec 31, 2021 | 643,707.00 |
| Sep 30, 2021 | 568,218.00 |
| Jun 30, 2021 | 640,207.00 |